Skip to main content
Premium Trial:

Request an Annual Quote

Genome Canada and Partners Offer CA $123M for Genomics and Proteomics; Winners to be Announced Tomorrow

NEW YORK, April 12 (GenomeWeb News) - Genome Canada said today that it will grant CA$123 million ($92 million) to large-scale genomics and proteomics projects, and will announce Ontario, Quebec, Prairie region, and British Columbia recipients tomorrow.


Half of the funding, distributed through the Applied Genomics and Proteomics Research in Human Health Competition, will come from Genome Canada, the other half from as yet undisclosed partners, a Genome Canada spokeswoman told GenomeWeb. The competition was launched last year after Genome Canada received CA$75 million from the 2003 federal budget.


The funding will focus on the development and application of genomics and proteomics tools to improve the prediction and treatment of disease, and on research on the impacts that these tools may have on health and the Canadian healthcare system.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.